This summary was created by AI, based on 1 opinions in the last 12 months.
The reviews for Grifols stock are conflicting, with some experts advising to avoid it due to an ongoing battle between longs and shorts. The stock seems to be a topic of contention in the market, with no clear consensus from the experts. Investors should approach with caution and conduct thorough research before making any decisions.
Grifols is a American stock, trading under the symbol GRFS-Q on the NASDAQ (GRFS). It is usually referred to as NASDAQ:GRFS or GRFS-Q
In the last year, 1 stock analyst published opinions about GRFS-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Grifols.
Grifols was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Grifols.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 1 stock analyst on Stockchase covered Grifols. The stock is worth watching.
On 2024-12-10, Grifols (GRFS-Q) stock closed at a price of $7.2.
It's a battleground between longs and shorts. Avoid.